摘要:
The present invention provides an antitumor agent and the like, which comprises as an active ingredient, a pyrimidine derivative represented by Formula (I): [wherein —X—Y—Z— represents —O—CR3═N— (wherein R3 represents a hydrogen atom, a substituted or unsubstituted aromatic heterocyclic group and the like) and the like, R1 represents —NR10R11 (wherein R10 and R11 may be the same or different, and each represents a hydrogen atom, substituted or unsubstituted lower alkyl and the like) and the like, R2 represents —NR13R14 (wherein R13 and R14 may be the same or different, and each represents a hydrogen atom, substituted or unsubstituted lower alkyl and the like)] or a pharmaceutically acceptable salt thereof.
摘要翻译:本发明提供了包含作为活性成分的式(I)所示的嘧啶衍生物的抗肿瘤剂等:[其中-X-Y-Z-表示-O-CR 3 = N-(其中R 3表示 氢原子,取代或未取代的芳族杂环基等)等,R 1表示-NR 10 R 11(其中R 10和R 11可以相同或不同,各自表示氢原子,取代或未取代的低级烷基等) 等等,R 2表示-NR 13 R 14(其中R 13和R 14可以相同或不同,各自表示氢原子,取代或未取代的低级烷基等)]或其药学上可接受的盐。
摘要:
The present invention provides an antitumor agent and the like, which comprises as an active ingredient, a pyrimidine derivative represented by Formula (I): [wherein —X—Y-Z- represents —O—CR3═N— (wherein R3 represents a hydrogen atom, a substituted or unsubstituted aromatic heterocyclic group and the like) and the like, R1 represents —NR10R11 (wherein R10 and R11 may be the same or different, and each represents a hydrogen atom, substituted or unsubstituted lower alkyl and the like) and the like, R2 represents —NR13R14 (wherein R13 and R14 may be the same or different, and each represents a hydrogen atom, substituted or unsubstituted lower alkyl and the like)] or a pharmaceutically acceptable salt thereof.
摘要翻译:本发明提供了包含作为活性成分的式(I)所示的嘧啶衍生物的抗肿瘤剂等:其中-XYZ-表示-O-CR3-N-(其中R3表示氢原子, 取代或未取代的芳族杂环基等)等,R 1表示-NR 10 R 11(其中R 10和R 11可以相同或不同,各自表示氢原子,取代或未取代的低级烷基等)等, R 2表示-NR 13 R 14(其中R 13和R 14可以相同或不同,各自表示氢原子,取代或未取代的低级烷基等)]或其药学上可接受的盐。
摘要:
[wherein m and n may be the same or different and each represents an integer of 1 to 3 wherein m+n is 4 or less; R1 represents —NR4R5 (wherein R4 and R5 may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted aralkyl or the like); R2 represents the above Formula (II), Formula (IV) or the like; A represents a single bond, —C(═O)—, —SO2—, —OC(═O)— or the like; and R3 represents substituted or unsubstituted lower alkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted aralkyl or the like] Bicyclic pyrimidine derivatives represented by the above Formula (I), or quaternary ammonium salts thereof, or pharmaceutically acceptable salts thereof, or the like, are provided. These have anti-inflammatory activities or modulation activities on the functions of TARC and/or MDC and are useful for treating and/or preventing a disease which is related to T cells, such as an allergic disease, an autoimmune disease or transplant rejection.
摘要:
[wherein m and n may be the same or different and each represents an integer of 1 to 3 wherein m+n is 4 or less; R1 represents —NR4R5 (wherein R4 and R5 may be the same or different and each represents a hydrogen atom, substituted or unsubstituted lower alkyl, substituted or unsubstituted aralkyl or the like); R2 represents the above Formula (II), Formula (IV) or the like; A represents a single bond, —C(═O)—, —SO2—, —OC(═O)— or the like; and R3 represents substituted or unsubstituted lower alkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted aralkyl or the like]Bicyclic pyrimidine derivatives represented by the above Formula (I), or quaternary ammonium salts thereof, or pharmaceutically acceptable salts thereof, or the like, are provided. These have anti-inflammatory activities or modulation activities on the functions of TARC and/or MDC and are useful for treating and/or preventing a disease which is related to T cells, such as an allergic disease, an autoimmune disease or transplant rejection.
摘要翻译:[其中m和n可以相同或不同,并且各自表示1〜3的整数,其中m + n为4以下; R 1表示-NR 4 R 5(其中R 4,R 5和R 5) 可以相同或不同,各自表示氢原子,取代或未取代的低级烷基,取代或未取代的芳烷基等); R 2表示上述式(II),式(IV)等; A表示单键,-C(-O) - , - SO 2 - , - OC(-O) - 等; 和R 3表示取代或未取代的低级烷基,取代或未取代的环烷基,取代或未取代的芳烷基等〕由上式(I)表示的双环嘧啶衍生物或其季铵盐或药学上可接受的盐 可接受的盐等。 它们具有对TARC和/或MDC的功能的抗炎活性或调节活性,并且可用于治疗和/或预防与T细胞相关的疾病,例如过敏性疾病,自身免疫疾病或移植排斥反应。
摘要:
A liquid crystal display device includes a liquid crystal (LC) panel; front and rear frames sandwiching therebetween the LC panel; a latch structure engaging together the LC panel and one of the front and rear frames. The latch structure includes a convex portion formed on one of the LC panel and the one of the front and rear panels and a concave portion formed on the other of the LC panel and the one of the front and rear frames to receive therein the convex portion, whereby the latch structure allows and restricts movement of the LC panel with respect to the one of the front and rear frames in a first direction normal to the LC panel and in a second direction parallel to the LC panel, respectively.
摘要:
A rotor for a vehicular alternating current generator has a relief space portion formed between axial holes of a pair of pole cores and a shaft for receiving therein a plastically deformed portion produced when the shaft is press-fitted in the axial holes of the pole cores. The relief space portion is located adjacent to a pair of closely contacting inner end faces of the pole cores so that the plastically deformed portion is let to move into a radially outward direction rather than further continuing movement in an axial direction within the relief space portion. The plastically deformed portion is thus prevented from entering between the inner end faces of the pole cores.
摘要:
A terminal (101) includes interfaces for communication with a mobile network (102) and a wireless LAN (103). A first IMS server (107) performs IMS call control processing relating to terminals located in the mobile network (102) and a second IMS server (111) relays a signal relating to IMS call control processing concerning terminals located in the wireless LAN (103). These IMS servers search for a mobile network packet gateway (106), a packet data gateway (110), and a gateway to be controlled by a route change request for requesting change of a packet transmission path and relay the route change request. The route change request provided from the terminal (101) is relayed by the IMS servers to provide the change request to all networks specified. The packet transmission path is changed by the gateway in accordance with the request. Thus, the terminal having the interfaces for both of the mobile communication network and the wireless LAN can select a network to use for each communication port.
摘要:
A radio network controller (104) according to the present invention outputs a context required for a terminal (110a) capable of communicating with a mobile communication network and a wireless local area network to communicate with the wireless local area network to the terminal (110a) among pieces of information input from wireless access gateways (105a, 105b) that control connection with one or more wireless local area networks (103a, 103b) and provide seamless handover of packet communication between the mobile communication network and the wireless LAN.
摘要:
A liquid crystal monitor incorporating therein a liquid crystal module having a direct backlight is configured to have receiving portions in a reflector 8 of the direct backlight that constitutes a liquid crystal module 13, in order to attach together the liquid crystal module 13 and a liquid crystal monitor member 12. The receiving portions are constituted by reflector extensions 111 that are formed by extending a bottom face of the reflector 8 toward a space between an inclined face of the reflector and an upper frame 2 of the liquid crystal module 13. Then, the liquid crystal monitor member 12 is fixed to the reflector extensions 111 by screws 407. Thus, the use of a space near the inclined face of the reflector allows a liquid crystal monitor to be thinned and reduced in its size and the width of monitor frame.
摘要:
An alternator has a rotor having magnetic poles along a circumferential direction and a cooling fan fixed to an end surface of the rotor in an axial direction. The fan has wing portions disposed along the circumferential direction. One wing portion has a fan base extending on or over first and second magnetic poles, first and second fixing members, respectively, fixing first and second fixing portions of the base to the first and second poles, and a fan blade extending from the fan base toward the axial direction. The base or blade has a boundary portion at which a boundary line between the blade and base crosses over a side line of the second pole, and a first distance between the first fixing portion and the boundary portion is substantially equal to a second distance between the second fixing portion and the boundary portion.